SUSAN SLUSKI: Open Payments
NPI 1912677691 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,803 in 97 payments from 21 companies in 2025. Trend: 2023 $2,077 · 2024 $1,476 · 2025 $1,803
Food & beverage: $1,803
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $417 |
| GlaxoSmithKline, LLC. | 22 | $193 |
| PFIZER INC. | 11 | $166 |
| Axsome Therapeutics, Inc. | 6 | $154 |
| Phathom Pharmaceuticals, Inc. | 5 | $153 |
| ABBVIE INC. | 5 | $99 |
| Kowa Pharmaceuticals America, Inc. | 1 | $88 |
| Lundbeck LLC | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
Products named: OTEZLA, NURTEC ODT, REPATHA, Auvelity, VOQUEZNA, REXULTI, TRELEGY ELLIPTA, ZORYVE.
Industry payments across TX — which companies pay providers there.
